Tristel plc develops, manufactures, and supplies infection and contamination control, and hygiene products in the United Kingdom and internationally. More Details
Flawless balance sheet with acceptable track record.
Share Price & News
How has Tristel's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TSTL is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: TSTL's weekly volatility (5%) has been stable over the past year.
7 Day Return
GB Medical Equipment
1 Year Return
GB Medical Equipment
Return vs Industry: TSTL exceeded the UK Medical Equipment industry which returned -12.1% over the past year.
Return vs Market: TSTL exceeded the UK Market which returned 1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Tristel's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StTristel plc's (LON:TSTL) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
3 weeks ago | Simply Wall StTristel (LON:TSTL) Has Rewarded Shareholders With An Exceptional 381% Total Return On Their Investment
1 month ago | Simply Wall StWhat Type Of Shareholders Own The Most Number of Tristel plc (LON:TSTL) Shares?
Is Tristel undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: TSTL (£5.9) is trading above our estimate of fair value (£4.52)
Significantly Below Fair Value: TSTL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: TSTL is poor value based on its PE Ratio (50.8x) compared to the GB Medical Equipment industry average (49.3x).
PE vs Market: TSTL is poor value based on its PE Ratio (50.8x) compared to the UK market (23.9x).
Price to Earnings Growth Ratio
PEG Ratio: TSTL is poor value based on its PEG Ratio (2.6x)
Price to Book Ratio
PB vs Industry: TSTL is overvalued based on its PB Ratio (9.4x) compared to the GB Medical Equipment industry average (3.9x).
How is Tristel forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TSTL's forecast earnings growth (19.2% per year) is above the savings rate (1%).
Earnings vs Market: TSTL's earnings (19.2% per year) are forecast to grow slower than the UK market (23.3% per year).
High Growth Earnings: TSTL's earnings are forecast to grow, but not significantly.
Revenue vs Market: TSTL's revenue (18.4% per year) is forecast to grow faster than the UK market (7.3% per year).
High Growth Revenue: TSTL's revenue (18.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TSTL's Return on Equity is forecast to be low in 3 years time (18.5%).
How has Tristel performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TSTL has high quality earnings.
Growing Profit Margin: TSTL's current net profit margins (15.7%) are lower than last year (16.2%).
Past Earnings Growth Analysis
Earnings Trend: TSTL's earnings have grown by 17.4% per year over the past 5 years.
Accelerating Growth: TSTL's earnings growth over the past year (13.8%) is below its 5-year average (17.4% per year).
Earnings vs Industry: TSTL earnings growth over the past year (13.8%) exceeded the Medical Equipment industry -29.1%.
Return on Equity
High ROE: TSTL's Return on Equity (18.2%) is considered low.
How is Tristel's financial position?
Financial Position Analysis
Short Term Liabilities: TSTL's short term assets (£17.2M) exceed its short term liabilities (£5.3M).
Long Term Liabilities: TSTL's short term assets (£17.2M) exceed its long term liabilities (£5.8M).
Debt to Equity History and Analysis
Debt Level: TSTL is debt free.
Reducing Debt: TSTL had no debt 5 years ago.
Debt Coverage: TSTL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TSTL has no debt, therefore coverage of interest payments is not a concern.
What is Tristel current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: TSTL's dividend (1.05%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.49%).
High Dividend: TSTL's dividend (1.05%) is low compared to the top 25% of dividend payers in the UK market (4.57%).
Stability and Growth of Payments
Stable Dividend: TSTL's dividend payments have been volatile in the past 10 years.
Growing Dividend: TSTL's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (55.6%), TSTL's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: TSTL's dividends in 3 years are forecast to be covered by earnings (56.6% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Paul Swinney (61 yo)
Mr. Paul C. Swinney serves as the Chief Executive Officer of Tristel Plc. since 1993 and serves as its Director. Mr. Swinney started his career with Brown, Shipley & Co in 1980. He worked for the European ...
CEO Compensation Analysis
Compensation vs Market: Paul's total compensation ($USD577.91K) is about average for companies of similar size in the UK market ($USD781.23K).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
|CEO & Executive Director||28.08yrs||UK£415.00k||1.38% |
|Finance Director||no data||UK£978.00k||0.38% |
|Executive Director||2.25yrs||UK£261.00k||2.04% |
|Independent Non-Executive Chairman||1.17yrs||UK£53.00k||no data|
|Non-Executive & Non-Independent Director||5.33yrs||UK£35.00k||0.093% |
|Senior Independent Non-Executive Director||2.08yrs||UK£35.00k||no data|
|Independent Non-Executive Director||0.75yr||UK£3.00k||no data|
|Independent Non-Executive Director||0.083yr||no data||no data|
Experienced Board: TSTL's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.9%.
Tristel plc's company bio, employee growth, exchange listings and data sources
- Name: Tristel plc
- Ticker: TSTL
- Exchange: AIM
- Founded: 1993
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: UK£275.432m
- Shares outstanding: 46.68m
- Website: https://www.tristel.com
Number of Employees
- Tristel plc
- Lynx Business Park
- Unit 1B
- CB8 7NY
- United Kingdom
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|TSTL||AIM (London Stock Exchange AIM Market)||Yes||Ordinary Shares||GB||GBP||Jun 2005|
|R1V||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jun 2005|
Tristel plc develops, manufactures, and supplies infection and contamination control, and hygiene products in the United Kingdom and internationally. The company operates through three segments: Hospital M...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/02/28 19:09|
|End of Day Share Price||2021/02/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.